AIDS and Behavior

, Volume 15, Issue 5, pp 885–896 | Cite as

Group Motivational Interviewing to Promote Adherence to Antiretroviral Medications and Risk Reduction Behaviors in HIV Infected Women

  • Marcia McDonnell HolstadEmail author
  • Colleen DiIorio
  • Mary E. Kelley
  • Kenneth Resnicow
  • Sanjay Sharma
Original Paper


We present the results of a clinical trial that tested the efficacy of using motivational interviewing (MI) in a group format to promote adherence to antiretroviral medications and risk reduction behaviors (RRB) in 203 predominately African American HIV infected women. It was compared to a group health promotion program. Participants were followed for 9 months. Adherence was measured by MEMS®; and RRB by self-report. Controlling for recruitment site and years on ART, no significant group by time effects were observed. Attendance (≥7/8 sessions) modified the effects. Higher MI attendees had better adherence at all follow-ups, a borderline significant group by time effect (p = 0.1) for % Doses Taken on Schedule, a significantly larger proportion who reported abstinence at 2 weeks, 6, and 9 months, and always used protection during sex at 6 and 9 months. Though not conclusive, the findings offer some support for using MI in a group format to promote adherence and some risk reduction behaviors when adequate attendance is maintained.


HIV/AIDS Motivational interviewing Antiretroviral adherence Risk reduction behaviors 



This research was funded by a grant from the National Institutes of Nursing Research R01 NR008094. We wish to thank the women who participated in this project and the providers and staff of the clinics from which we recruited and conducted the study. We also acknowledge the work of the KHARMA Project staff, including Bridget Jones, Carol Corkran, Sally Carpentier, Versey McLendon, Lisa Weaver, Kate Yeager, Samaha Norris, Ilya Teplinskiy, and Frances McCarty.


  1. 1.
    CDC. Effect of antiretroviral therapy on risk of sexual transmission of HIV infection and superinfection: centers for disease control and prevention. 2009 September.Google Scholar
  2. 2.
    CDC. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2009 [cited 2009 October 18].Google Scholar
  3. 3.
    Remien RH, Exner T, Kertzner RM, Ehrhardt AA, Rotheram-Borus MJ, Johnson MO, et al. Depressive symptomatology among HIV-positive women in the era of HAART: a stress and coping model. Am J Community Psychol. 2006;38(3–4):275–85.PubMedCrossRefGoogle Scholar
  4. 4.
    Wilson TE, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34(4):529–34.PubMedCrossRefGoogle Scholar
  5. 5.
    Kalichman S, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect. 2003;79:59–61.PubMedCrossRefGoogle Scholar
  6. 6.
    Diamond C, Richardson JL, Milam J, Stoyanoff S, McCutchan JA, Kemper C, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J AIDS. 2005;39(2):211–8.Google Scholar
  7. 7.
    Remien RH, Exner TM, Morin SF, Ehrhardt AA, Johnson MO, Correale J, et al. Medication adherence and sexual risk behavior among HIV-infected adults: implications for transmission of resistant virus. AIDS Behav. 2007;11(5):663–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Donnell D, Baeten jM, Kiarie j, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Bennett JA, Young HM, Nail LM, Winters-Stone K, Hanson G. A telephone-only motivational intervention to increase physical activity in rural adults: a randomized controlled trial. Nurs Res. 2008;57(1):24–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Resnicow K, Wallace DC, Jackson A, Digirolamo A, Odom E, Wang T, et al. Dietary change through African American churches: baseline results and program description of the eat for life trial. J Cancer Educ. 2000;15(3):156–63.Google Scholar
  11. 11.
    Smith DE, Heckemeyer CM, Kratt PP, Mason DA. Motivational interviewing to improve adherence to a behavioral weight-control program for older obese women with NIDDM. A pilot study. Diabetes Care. 1997;20(1):52–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Stein MD, Herman DS, Anderson BJ. A motivational intervention trial to reduce cocaine use. J Subst Abuse Treat. 2009;36(1):118–25.PubMedCrossRefGoogle Scholar
  13. 13.
    Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J AIDS. 2007;46(4):443–50.Google Scholar
  14. 14.
    Velasquez MM, von Sternberg K, Johnson DH, Green C, Carbonari JP, Parsons JT. Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial. J Consult Clin Psychol. 2009;77(4):657–67.PubMedCrossRefGoogle Scholar
  15. 15.
    DiIorio C, McCarty F, Resnicow K, McDonnell Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.PubMedCrossRefGoogle Scholar
  16. 16.
    Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J AIDS. 2006;42(1):42–51.Google Scholar
  17. 17.
    Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J AIDS. 2006;41(1):44–52.Google Scholar
  18. 18.
    Callahan EJ, Flynn NM, Kuenneth CA, Enders SR. Strategies to reduce HIV risk behavior in HIV primary care clinics: brief provider messages and specialist intervention. AIDS Behav. 2007;11(5 Suppl):S48–57.PubMedCrossRefGoogle Scholar
  19. 19.
    Golin CE, Patel S, Tiller K, Quinlivan EB, Grodensky CA, Boland M. Start talking about risks: development of a motivational interviewing-based safer sex program for people living with HIV. AIDS Behav. 2007;11(5 Suppl):S72–83.PubMedCrossRefGoogle Scholar
  20. 20.
    Nollen C, Drainoni ML, Sharp V. Designing and delivering a prevention project within an HIV treatment setting: lessons learned from a specialist model. AIDS Behav. 2007;11(5 Suppl):S84–94.PubMedCrossRefGoogle Scholar
  21. 21.
    Rutledge SE. Single-session motivational enhancement counseling to support change toward reduction of HIV transmission by HIV positive persons. Arch Sex Behav. 2007;36(2):313–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Ingersoll K, Wagner C. Motivational enhancement groups for the Virginia substance abuse treatment outcome evaluation (SATOE) model: theoretical background and clinical guidelines. Richmond, VA: Virginia Addiction Technology Transfer Center Virginia Commonwealth University/Medical College of Virginia; 1998.Google Scholar
  23. 23.
    Morrison-Beedy D, Carey MP, Kowalski J, Tu X. Group-based HIV risk reduction intervention for adolescent girls: evidence of feasibility and efficacy. Res Nurs Health. 2005;28(1):3–15.PubMedCrossRefGoogle Scholar
  24. 24.
    Holstad MM, DiIorio C, Magowe MK. Motivating HIV positive women to adhere to antiretroviral therapy and risk reduction behavior: the KHARMA Project. Online J Issues Nurs. 2006;11(1):5.PubMedGoogle Scholar
  25. 25.
    Ebbert DW, Connors H. Standardized patient experiences: evaluation of clinical performance and nurse practitioner student satisfaction. Nurs Educ Perspect. 2004;25(1):12–5.PubMedGoogle Scholar
  26. 26.
    CDC. Revision of the CDC surveillance case definition for acuired immunodeficiency syndrome. MMWR. 1987;36(1S):82–94.Google Scholar
  27. 27.
    CDC. Core measures for HIV/STD risk behavior and prevention: Questionnaire-based measurement for surveys and other data systems. Sexual behavior questions version 5.00. 2001 [5/27/2003.].Google Scholar
  28. 28.
    Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET vaccine preparedness study protocol team. Am J Epidemiol. 2000;152(2):99–106.PubMedCrossRefGoogle Scholar
  29. 29.
    Williams M, Bowen A, Ross M, Freeman R, Elwood W. Perceived compliance with AZT dosing among a sample of African-American drug users. Int J STD AIDS. 2000;11(1):57–63.PubMedCrossRefGoogle Scholar
  30. 30.
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRefGoogle Scholar
  31. 31.
    Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedGoogle Scholar
  32. 32.
    Jones DL, McPherson-Baker S, Lydston D, Camille J, Brondolo E, Tobin JN, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST Women’s Project. AIDS Behav. 2007;11(1):79–86.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Marcia McDonnell Holstad
    • 1
    Email author
  • Colleen DiIorio
    • 2
  • Mary E. Kelley
    • 2
  • Kenneth Resnicow
    • 3
  • Sanjay Sharma
    • 4
  1. 1.Nell Hodgson School of NursingEmory UniversityAtlantaUSA
  2. 2.Rollins School of Public HealthEmory UniversityAtlantaUSA
  3. 3.School of Public HealthUniversity of MichiganMIUSA
  4. 4.School of MedicineEmory UniversityAtlantaUSA

Personalised recommendations